Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Legal Status: Not FDA-approved for human use
In addition to venous occlusion-induced lesions (Vukojevic et al., 2018
Safety and Medical Supervision Peptides should be used under the supervision of a licensed medical professional trained in peptide therapy
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
US$ 26.97
US$ 21.99
US$ 29.36
US$ 20.33
